Key result
The PPARGC1A Gly482Ser variant showed no statistically significant association with BMI, type 2 diabetes, or gout, and lacked compelling evidence of natural selection in Polynesian populations.
Observational (n=2,313)
Yes
The PPARGC1A gene does not show compelling evidence of natural selection and should not be considered a candidate thrifty gene locus in Pacific populations.
PPARGC1A Gly482Ser should not guide clinical risk assessment in Polynesians; leaves open alternative genetic contributors to metabolic traits.
BACKGROUND: The gene PPARGC1A, in particular the Gly482Ser variant (rs8192678), had been proposed to be subject to natural selection, particularly in recent progenitors of extant Polynesian populations. Reasons include high levels of population differentiation and increased frequencies of the derived type 2 diabetes (T2D) risk 482Ser allele, and association with body mass index (BMI) in a small Tongan population. However, no direct statistical tests for selection have been applied. RESULTS: ) was smallest between Asian and Pacific populations (New Zealand Māori ≤ 0.35, Samoan ≤ 0.20). When compared to European (New Zealand Māori ≤ 0.40, Samoan ≤ 0.25) or African populations (New Zealand Māori ≤ 0.80, Samoan ≤ 0.66) this differentiation was larger. We did not find any strong evidence for departure from neutral evolution at this locus when applying any of the other statistical tests for selection. However, using the same analytical methods, we found evidence for selection in specific populations at previously identified loci, indicating that lack of selection was the most likely explanation for the lack of evidence of selection in PPARGC1A. CONCLUSION: We conclude that there is no compelling evidence for selection at this locus, and that this gene should not be considered a candidate thrifty gene locus in Pacific populations. High levels of population differentiation at this locus and the reported absence of the derived 482Ser allele in some Melanesian populations, can alternatively be explained by multiple out-of-Africa migrations by ancestral progenitors, and subsequent genetic drift during colonisation of Polynesia. Intermediate 482Ser allele frequencies in extant Western Polynesian populations could therefore be due to recent admixture with Melanesian progenitors.
No takes yet. Share an insight, caveat, or question.
Cadzow et al. (2016) conducted an observational in Type 2 Diabetes, Gout, Obesity (n=2,313). PPARGC1A Gly482Ser variant (rs8192678) vs. Non-carriers / reference allele was evaluated on Association between Gly482Ser variant and BMI, type 2 diabetes, or gout. The PPARGC1A Gly482Ser variant showed no statistically significant association with BMI, type 2 diabetes, or gout, and lacked compelling evidence of natural selection in Polynesian populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: